72.19.Z - Scientific research and development activities
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.91.Z - Intermediary retail sale, non-specialized
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
86.90.D - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | -0 | -0 | 46,2 |
EBITDA | 0,2 | -0 | -0 | 63,7 |
Short time liabilities | 0 | 0,1 | 0,1 | 11,4 |
Equity capital | 0,5 | 0,5 | 0,5 | -2,3 |
Operating profit (EBIT) | 0,2 | -0 | -0 | 58,1 |
Assets | 0,6 | 0,6 | 0,6 | -0,2 |
Net profit (loss) | 0,2 | -0 | -0 | 46,2 |
Cash | 0 | 0 | 0 | -100 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,2 | 6,8 |
Net income from sale | 0,2 | 0 | 0 | 0 |
Working assets | 0,6 | 0,6 | 0,6 | 0,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 42,5 | -4,2 | -2,3 | 1,9 |
Equity capital to total assets | 80,1 | 76,9 | 75,3 | -1,6 |
Gross profit margin | 90,3 | 176,4 | ||
EBITDA Margin | 91,6 | -34,3 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 74 | 2 147 483 648 | 2 147 483 648 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane